Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $5.2150 (4.51%) ($5.2150 - $5.2150) on Thu. May. 12, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.29% (three month average) | RSI | 30 | Latest Price | $5.2150(4.51%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -5.3% a day on average for past five trading days. | Weekly Trend | ATRA declines -9.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(45%) IBB(43%) ARKK(42%) ARKG(41%) XAR(40%) | Factors Impacting ATRA price | ATRA will decline at least -2.645% in a week (0% probabilities). VIXM(-39%) VXX(-24%) UNG(-18%) USO(-11%) TLT(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.645% (StdDev 5.29%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-16.44(-415.24%) | Resistance Level | $6.77 | 5 Day Moving Average | $5.7(-8.51%) | 10 Day Moving Average | $6.25(-16.56%) | 20 Day Moving Average | $6.77(-22.97%) | To recent high | -65.3% | To recent low | 4.5% | Market Cap | $388m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |